Pfizer, FDA Hid Data Showing Clinical Trials Failed, Says Former BlackRock Advisor Edward Dowd

🇺🇸@COVID19Up: In an interview with Naomi Wolf, investment advisor Edward Dowd discussed why investors are dumping COVID-19 vaccine makers’ stocks. Dowd, a former managing director with BlackRock from 2002 to 2012, grew BlackRock’s growth strategy from $2 billion-$14 billion over 10 years.

Wolf introduced Dowd:

“He’s the extraordinarily kind of courageous, well-informed whistleblower who has come forward to explain to audiences why in his view, Pfizer has committed a fraud.”

Dowd described how his initial caution about taking the experimental COVID-19 vaccine led him to research data related to Pfizer’s clinical trials.

Dowd told Wolf:

“I learned from a friend in the biotech industry that Pfizer had failed its all-cause mortality endpoint in the initial trial … All-cause mortality is the gold standard in any drug trial at the FDA. When you fail that endpoint, the drug is not approved.”

When Big Pharma and the U.S. FDA were unwilling to release vaccine safety data, Dowd grew even more skeptical about the COVID-19 vaccines, he said, and was compelled to speak out privately and publicly about what he believed was a major deception:

“I got more loud about fraud when the FDA decided to hide the clinical data for 75 years. I’m an investor, so let me just say how I think about the world. I don’t wait for people to tell me what just happened. My job was to come up with an analysis, mosaic and investment thesis, and then over time I’d be proven right.”

“So I don’t wait for The New York Times, The Wall Street Journal or The Washington Post to tell me anything. Because by the time that happens, the opportunity to make money is lost. So I started screaming fraud as soon as I saw that—because it’s unprecedented to hide data from the public.”